Mit Magzter GOLD unbegrenztes Potenzial nutzen
Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur
Versuchen GOLD - Frei
What counts as 'modern' in health insurance: who decides?
Mint Bangalore
|February 21, 2025
In an Ombudsman ruling, my claim for Bevacizumab (on the market since 2017) was limited to 25% under the policy's 'modern treatment' coverage. How is 'modern' defined, and is there a timeframe to determine it? Should any treatment available for this long be classified as 'modern'? Please provide detailed criteria or references. -Name withheld on request
Bevacizumab stands as a beacon of hope for countless patients fighting cancer, offering not just a treatment but a renewed sense of possibility during some of life's challenging moments. As a monoclonal antibody that targets vascular endothelial growth factor, it disrupts the blood supply that tumors need to grow and spread, thereby offering a critical line of defense in the battle against metastatic colorectal cancer and non-squamous non-small cell lung cancer.
Diese Geschichte stammt aus der February 21, 2025-Ausgabe von Mint Bangalore.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Bangalore
Mint Bangalore
OTTs reinforce legal teams as data privacy rules kick in
DPDP Act rules have been notified and a new data-protection board will oversee compliance
2 mins
November 24, 2025
Mint Bangalore
Wealthy's ₹130-cr fundraise fuels bet on adviser-led wealth-tech
Even as DIY investing apps dominate headlines, a chunk of mutual fund money in India is still routed through human advisers.
2 mins
November 24, 2025
Mint Bangalore
CAG plans shift to live audits to curb public funds misuse
The overhaul is designed to flag tendering lapses, execution delays and potential losses early
2 mins
November 24, 2025
Mint Bangalore
Is there a formula to measure talent?
Corporate talent is not high intelligence or fame; it is the capabilities— skills, knowledge, and expertise—required to multiply business value
4 mins
November 24, 2025
Mint Bangalore
Govt enforces stricter rules for blood screening
Move aims to curb regulatory non-compliance after six children in Jharkhand contract HIV
1 mins
November 24, 2025
Mint Bangalore
Sebi, MF heads to discuss plan to cap broker fee
The proposed measure is part of Sebi's move to overhaul the costs MFs charge investors—known as TER.
1 mins
November 24, 2025
Mint Bangalore
US share in exports falling: SBI report
The share of India’s merchandise exports to other countries increased as shipments to the US declined since July, indicating diversification of export basket across product categories, according to an SBI research report.
1 min
November 24, 2025
Mint Bangalore
Labour codes could act as an economic catalyst
If enforced as envisioned, the four codes can yield a more secure workforce and strengthen India's economy. Employers should not just comply but also focus on their collective interest
2 mins
November 24, 2025
Mint Bangalore
'Stay invested in the stock market, everything is for the long haul'
Veteran value investor Ramesh Damani is ignoring doomsday warnings about a US tech stock correction and noises surrounding corporate earnings growth trajectory back home, staying loyal instead to his credo of long-term investments, using a bottom -up approach. He remains unconcerned about short term market corrections, advising investors to
6 mins
November 24, 2025
Mint Bangalore
India to curb antibiotic use in animals to control drug resistance
India has unveiled its next-generation national action plan on antimicrobial resistance (AMR 2.0) for 2025-2029, to curb misuse of antibiotics across humans and animals as drug-resistant infections emerge as a major national health threat.
2 mins
November 24, 2025
Listen
Translate
Change font size